How has Haemonetics's increase (decrease) in accounts receivable changed year-over-year?

Haemonetics's increase (decrease) in accounts receivable increased by 315.2% year-over-year, from -$10.34M to $22.24M.

What is the long-term trend for Haemonetics's increase (decrease) in accounts receivable?

Over 3 years (2022 to 2026), Haemonetics's increase (decrease) in accounts receivable has grown at a -24.8% compound annual growth rate (CAGR), from $34.97M to $14.88M.

Haemonetics HAE Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

TFX

TeleflexTFX

$25.01M+129%

LivaNovaLIVN

$14.67M+277%

Baxter InternationalBAX

-$152M-485%

RepligenRGEN

-$3.19M-132%

Merit Medical SystemsMMSI

——

SolventumSOLV

——

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.31B-18.0%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's increase (decrease) in accounts receivable?: Haemonetics (HAE) reported increase (decrease) in accounts receivable of $22.24M in Q1 2026.
How has Haemonetics's increase (decrease) in accounts receivable changed year-over-year?: Haemonetics's increase (decrease) in accounts receivable increased by 315.2% year-over-year, from -$10.34M to $22.24M.
What is the long-term trend for Haemonetics's increase (decrease) in accounts receivable?: Over 3 years (2022 to 2026), Haemonetics's increase (decrease) in accounts receivable has grown at a -24.8% compound annual growth rate (CAGR), from $34.97M to $14.88M.